| 2024-01-05 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | COO and General Counsel | 22,841 0.021% | $35.27 | $805,716 | -23.8% | |
| 2024-01-04 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | COO and General Counsel | 1,600 0.0014% | $32.63 | $52,208 | -20.56% | |
| 2024-01-03 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | COO and General Counsel | 8,749 0.0082% | $32.28 | $282,439 | -13.66% | |
| 2023-01-05 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | COO and General Counsel | 15,000 0.0142% | $37.39 | $560,850 | -17.96% | |
| 2023-01-03 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | COO and General Counsel | 17,500 0.0163% | $38.33 | $670,802 | -20.98% | |
| 2022-01-05 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | General Counsel | 32,500 0.0316% | $61.72 | $2.01M | -34.2% | |
| 2021-02-08 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | General Counsel | 90,000 0.0867% | $88.46 | $7.96M | -24.08% | |
| 2021-01-06 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | General Counsel | 25,000 0.0234% | $72.41 | $1.81M | -7.92% | |
| 2020-01-06 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | General Counsel | 14,625 0.0146% | $60.12 | $879,261 | -27.55% | |
| 2019-05-28 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | General Counsel | 30,000 0.0314% | $24.88 | $746,400 | +36.81% | |
| 2019-01-18 | Sale | Arrowhead Pharmaceuticals, Inc. ARWR | General Counsel | 144,000 0.152% | $14.43 | $2.08M | +93.94% |